Scott & Selber, Inc. Illumina, Inc. Transaction History

Scott & Selber, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$292.7 - $370.96 $2.05 Million - $2.6 Million	-7,014 Closed	0 $0
Q3 2020 Oct 27, 2020	BUY	$268.51 - $400.74 $9,129 - $13,625	34 Added 0.49%	7,014 $2.17 Million
Q2 2020 Aug 04, 2020	SELL	$256.46 - $373.01 $22,312 - $32,451	-87 Reduced 1.23%	6,980 $2.59 Million
Q1 2020 Apr 28, 2020	BUY	$209.2 - $335.53 $458,357 - $735,146	2,191 Added 44.93%	7,067 $1.93 Million
Q4 2019 Feb 07, 2020	BUY	$288.29 - $335.49 $1.41 Million - $1.64 Million	4,876 New	4,876 $1.62 Million
Q3 2019 Oct 17, 2019	SELL	$266.84 - $378.23 $1.79 Million - $2.53 Million	-6,693 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$300.59 - $368.15 $85,668 - $104,922	285 Added 4.45%	6,693 $2.46 Million
Q1 2019 May 03, 2019	BUY	$272.57 - $321.18 $1.75 Million - $2.06 Million	6,408 New	6,408 $1.99 Million

852

138M

1.41M

1.66M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.2B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Scott & Selber, Inc., based on Form 13F filings with the SEC.

Stay updated on Scott & Selber, Inc. with notifications on news.